Amanote Research

Amanote Research

    RegisterSign In

Lenvatinib

Cancer Control - United States
doi 10.1177/1073274818789361
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineOncologyHematology
Date

January 1, 2018

Authors
Koichi SuyamaHirotaka Iwase
Publisher

SAGE Publications


Related search

Treatment With Lenvatinib to Anaplastic Thyroid Cancer :

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2018English

Lenvatinib vs. Palliative Therapy for Stage IVC Anaplastic Thyroid Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2019English

Administration of Lenvatinib to Patients With Anaplastic Thyroid Cancer

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2018English

Lenvatinib and Its Use in the Treatment of Unresectable Hepatocellular Carcinoma

Future Oncology
MedicineCancer ResearchOncology
2018English

Cohort Study Exploring the Effect of Lenvatinib on Differentiated Thyroid Cancer

Endocrine Journal
EndocrinologyMetabolismDiabetes
2018English

Lenvatinib as a Novel Treatment for Anaplastic Thyroid Cancer: A Retrospective Study

Oncology Letters
Cancer ResearchOncology
2018English

Phase 2 Study of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma

Journal of Gastroenterology
Gastroenterology
2016English

Optimal Use of Lenvatinib in the Treatment of Advanced Thyroid Cancer

Cancers of the Head & Neck
2017English

Effects of Ketoconazole on the Pharmacokinetics of Lenvatinib (E7080) in Healthy Participants

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy